SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Trader J's Inner Circle
NVDA 183.61+1.4%Dec 22 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: American Spirit who wrote (13512)4/28/1999 4:25:00 PM
From: StockHawk  Read Replies (1) of 56535
 
Spirit - PFE >>And PFE is the most highly recommended big-cap drug co. <<

For good reason. PFE probably has the best R&D/drug pipeline in the industry and they also probably have the best marketing/sales machine. Recently introduced Celebrex was the most successful drug launch in history (this is a Monsanto drug which Pfizer is co-promoting) Viagra was the most successful when it was launched (it is now 2nd) and Lipator was the most successful when it was launched (it is now considered the third best drug launch in history) (Lipator is a another drug Pfizer is co-promiting). So you have two forces pulling this co forward. They have great home grown products and they are the company of choice to promote the drugs of other firms. PFE is a long term hold for me and I am adding more here.

StockHawk
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext